The emergence of parasites resistant to artemisinin—the gold-standard drug for treating malaria—poses a threat to global health. Left unchecked, a drug-resistant strain could spread to India and Africa. In The Wall Street Journal Asia, BCG’s Trish Stroman and Harvard’s Jay Winsten explain why Burma is key to containing the spread of artemisinin resistance.
Your Pop up Blocker is enabled. Please disable the pop up blocker to load the window.
Switch to the bcg.perspectives web app for an optimized browsing
experience from your tablet. Read BCG's latest content and create your own customized version of the site.